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Activation of the integrated stress response (ISR) by a variety of
stresses triggers phosphorylation of the α-subunit of translation ini-
tiation factor eIF2. P-eIF2α inhibits eIF2B, the guanine nucleotide ex-
change factor that recycles inactive eIF2•GDP to active eIF2•GTP. eIF2
phosphorylation thereby represses translation. Persistent activation
of the ISR has been linked to the development of several neurolog-
ical disorders, and modulation of the ISR promises new therapeutic
strategies. Recently, a small-molecule ISR inhibitor (ISRIB) was iden-
tified that rescues translation in the presence of P-eIF2α by facilitat-
ing the assembly of more active eIF2B. ISRIB enhances cognitive
memory processes and has therapeutic effects in brain-injured mice
without displaying overt side effects. While using ISRIB to investigate
the ISR in picornavirus-infected cells, we observed that ISRIB rescued
translation early in infection when P-eIF2α levels were low, but not
late in infection when P-eIF2α levels were high. By treating cells with
varying concentrations of poly(I:C) or arsenite to induce the ISR, we
provide additional proof that ISRIB is unable to inhibit the ISR when
intracellular P-eIF2α concentrations exceed a critical threshold level.
Together, our data demonstrate that the effects of pharmacological
activation of eIF2B are tuned by P-eIF2α concentration. Thus, ISRIB
can mitigate undesirable outcomes of low-level ISR activation that
may manifest neurological disease but leaves the cytoprotective ef-
fects of acute ISR activation intact. The insensitivity of cells to ISRIB
during acute ISR may explain why ISRIB does not cause overt toxic
side effects in vivo.
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Eukaryotic cells respond to intrinsic stress [e.g., endoplasmicreticulum (ER) stress or oncogene activation] as well as ex-
trinsic stress (e.g., glucose or amino acid deprivation, hypoxia, or
virus infection) by activating the integrated stress response
(ISR). The ISR comprises a complex, cytoprotective signaling
pathway aimed at reducing global protein synthesis while allowing
translation of a few select mRNAs to promote cell recovery and
survival (1, 2).
A key factor in translation initiation is eIF2, a heterotrimeric
complex composed of an α-, β-, and γ-subunit. eIF2γ binds GTP
and initiator Met-tRNA (Met-tRNAi) (3) to form a eIF2•GTP•Met-
tRNAi ternary complex (TC). The TC, together with other trans-
lation initiation factors and the 40S ribosomal subunit, scans the
mRNA for AUG start codons. Upon base pairing of Met-tRNAi to
the start codon, eIF2-bound GTP is hydrolyzed and eIF2•GDP is
released from the translation complex. To reactivate eIF2, GDP is
displaced by eIF2B, a guanidine nucleotide exchange factor (GEF).
eIF2B is a large decamer composed of a homodimer of a hetero-
pentamer protein complex (4). The interplay between eIF2 and
eIF2B is targeted by the ISR to regulate translation efficiency. In
response to stress, eIF2 kinases are activated and subsequently
phosphorylate a single, conserved Ser-51 residue in eIF2α. Four
eIF2α kinases have been identified: protein kinase R (PKR), which is
activated by recognition of “nonself” (e.g., viral) RNA (5, 6); PKR-
like endoplasmic reticulum kinase (PERK), which responds to an
accumulation of misfolded proteins in the ER (7); general control
nonderepressible 2 (GCN2), which is activated by amino acid star-
vation and UV light (8, 9); and heme-regulated inhibitor (HRI),
which is activated at low levels of heme and exposure to heavy metals
(10). Phosphorylation of eIF2α inhibits eIF2B by stabilizing its asso-
ciation with eIF2•GDP (11). Since the levels of eIF2B levels are low
compared with those of eIF2 (12), limited quantities of P-eIF2α can
efficiently deplete available eIF2B pools and thus inhibit eIF2B-
mediated nucleotide exchange (11). Impairing eIF2B leads to the
general inhibition of protein synthesis and to the aggregation of in-
active translation initiation complexes into stress granules (SGs). At
the same time, it promotes translation of a selected group of genes,
such as ATF4, a transcription factor that promotes cell recovery and
survival. These particular mRNAs contain short, upstream open-
reading frames (uORFs), whose inhibitory function is suppressed
when TCs become limiting upon ISR induction.
Dephosphorylation of eIF2α signals to terminate the ISR and
restore protein synthesis (13). However, upon severe or long-
lasting cellular stress, the capacity of the ISR to resolve the
stress can fail. In this case, the ISR initiates a cell death program
through the increased production of proapoptotic components
(14). ISR kinase-mediated phosphorylation and dephosphorylation
of eIF2α are central to normal cell functioning. They play roles in
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the regulation of translation during mitosis and thereby in cytoki-
nesis and cell proliferation (15–17).
Dysregulation of the ISR has been linked to cancer, diabetes, and
inflammation (18–20). Moreover, there is growing evidence of
persistent, smoldering ISR activation in neurodegenerative diseases
and conditions exhibiting memory consolidation defects, such as
traumatic brain injury (18–21). Pharmacological modulation of the
ISR has been proposed as a promising therapeutic strategy to treat
these neurological conditions that are characterized by chronic
eIF2α phosphorylation. Recently, a small-molecule ISR inhibitor,
ISRIB, was identified to rescue protein translation and prevent SG
formation in the presence of P-eIF2α (19, 22). Structural, genetic
and biochemical evidence revealed that ISRIB targets eIF2B (23–
26). ISRIB enhances eIF2B’s GEF activity by promoting the as-
sembly of the fully active heterodecameric eIF2B complex from
smaller subcomplexes (24, 25). ISRIB’s ability to restore the cellular
translational capacity upon ISR activation implicated it as a
promising tool to modulate ISR-regulated neurological processes
and diseases. Indeed, ISRIB enhances cognitive memory processes
(19), has beneficial effects in prion-diseased mice (27), and reme-
dies cognitive defects resulting from brain injuries (21). Re-
markably, ISRIB does so without causing the side effects that were
previously observed upon suppressing the ISR by approaches that
directly targeted eIF2α kinases in vivo (27–29).
In this study, we initially set out to investigate the effect of ISRIB
in cells infected with an ISR-inducing recombinant picornavirus
lacking its PKR antagonist (30, 31). We observed that ISRIB
suppressed the ISR early in infection, when the amount of viral
dsRNA and the level of P-eIF2α were relatively low, but not late in
infection, when dsRNA and P-eIF2α levels were relatively high.
This prompted us to investigate more systematically ISRIB’s ability
to rescue translation at varying levels of P-eIF2α. To this end, we
treated cells with different concentrations of poly(I:C) or arsenite,
which trigger the ISR by activating PKR or HRI, respectively. The
results show that ISRIB inhibits the ISR when P-eIF2α levels are
below a critical threshold (i.e., 45–70% of the maximum phos-
phorylation), but not when P-eIF2α levels exceed this threshold
level. These findings are consistent with in vitro studies (24) and
demonstrate that potentially negative effects of pharmacological
eIF2B assembly may be sidestepped under conditions of enhanced
phosphorylation of eIF2. The observation that ISRIB is only
functional within a narrow range of P-eIF2α concentrations may
explain the lack of toxic side effects that ISRIB displays in vivo.
Results
ISRIB Inhibits the ISR Induced by a Recombinant Picornavirus only
Early in Infection, When P-eIF2α Levels Are Relatively Low. Picorna-
viruses, like other RNA viruses, synthesize dsRNA in an in-
dispensable intermediate step of their replication process. These
dsRNAs are detected by PKR to activate the ISR and limit the
production of viral proteins. As a countermeasure, many viruses
have evolved strategies to delay or suppress this antiviral response.
We set out to test the ability of ISRIB to inhibit the ISR during
infection with a recombinant encephalomyocarditis virus (EMCV)
containing debilitating mutations in a zinc-finger domain of its
Leader protein, the viral protein that serves as PKR antagonist
(EMCV-LZn) (32, 33). To assess the effect of ISRIB on the ISR in
virus-infected cells, we treated HeLa-R19 cells with ISRIB for 1 h
from 5 h postinfection (p.i.) until 6 h p.i. and monitored active
translation using a ribopuromycilation assay for 15 min at the 6-h
time point p.i. (34). This time point is relatively late in the infection
cycle, as a single round of replication of this virus takes only 6–8 h
(Fig. 1A). Viral dsRNA replication intermediates are readily de-
tected at ∼4 h p.i. and reach a maximum level at ∼6 h p.i. (Fig. 1B).
As a positive control, we treated cells with 50 μM sodium arsenite, a
commonly used method to trigger the ISR via HRI activation (35,
36). In both arsenite-treated and virus-infected cells, we observed
eIF2α phosphorylation and concomitant translational repression.
Remarkably, ISRIB treatment failed to restore translation efficiency
in infected cells, while translation in arsenite-treated cells was largely
rescued (Fig. 1C). Similar results were obtained in U2OS cells, sug-
gesting that this effect was not cell-type specific (SI Appendix, Fig. S1).
We noted that the level of eIF2α phosphorylation in virus-infected
cells at 6 h p.i. was higher than in cells treated with 50 μM arsenite,
suggesting a correlation between ISRIB’s ability to inhibit the ISR
and the extent of eIF2α phosphorylation.
We hypothesized that ISRIB is only functional when P-eIF2α
levels are relatively low. To test this notion, we monitored the ef-
fects of ISRIB on SG formation in EMCV-LZn–infected cells at
earlier time points p.i., when smaller amounts of dsRNA were
present. ISRIB suppressed SG formation at the earliest time point
at which SGs were detected (4 h p.i.) but not later in infection (Fig.
2A), suggesting that ISRIB’s ability to antagonize the ISR indeed
depends on the concentration of the stress trigger. We next quan-
tified intracellular P-eIF2α levels by flow cytometry. Indeed, the
level of P-eIF2α in virus-infected cells increased gradually from 3 to
6 h p.i. (Fig. 2B), correlating with the timing of dsRNAs accumu-
lation (Fig. 1B) and the appearance of SGs (Fig. 2A). Furthermore,
our data indicated that a plateau level of P-eIF2α was reached late
in infection (5–6 h p.i.). To rule out that this observed maximum
level of P-eIF2α was caused by a detection limit of our flow
cytometry approach, we compared flow cytometry (SI Appendix,
Fig. S2A) and Western blotting (SI Appendix, Fig. S2B) as readout
methods for P-eIF2α levels in cells stressed with increasing arsenite
concentrations. The arsenite concentration at which the plateau
level of P-eIF2α level was reached (∼250 μM) was similar between
the two detection methods. By comparing Western blot band
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Fig. 1. ISRIB does not inhibit virus-induced ISR activity late in infection. (A
and B) HeLa-R19 cells were infected at MOI 20 with EMCV-LZn. (A) At the
indicated time points, EMCV-LZn genome copies per cell were quantified by
qPCR. A representative of two independent experiments is shown. Error bars
indicate SEM of triplicate measurements. (B) At the same time points, dsRNA
content in EMCV-LZn–infected cells was analyzed by flow cytometry (n = 3).
(C) Cells were infected with EMCV-LZn for 6 h or treated with 50 μM arsenite
for 1 h. One hour before harvesting, cells were treated with 200 nM ISRIB or
left untreated. Fifteen minutes before harvesting, all samples were treated
with 20 μg/mL puromycin. Arsenite and EMCV-LZn were kept the cells during
these treatments. Subsequently, cells were harvested and analyzed by
Western blot, using the indicated antibodies. A representative of two in-
dependent experiments is shown.
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intensity ratios of P-eIF2α and (total) eIF2α in cell lysates to
those of purified eIF2α samples containing known percentages
of P-eIF2α (SI Appendix, Fig. S3), we furthermore showed that
this upper limit of P-eIF2α levels (defined as 100% P-eIF2α)
represents almost complete phosphorylation of the cellular eIF2α
pool. Collectively, these data demonstrate that the maximum level
of eIF2α phosphorylation observed under harsh stress condi-
tions represents the upper limit of eIF2α phosphorylation that
was reached.
Taken together, the data suggest that during EMCV-LZn in-
fection, increasing concentrations of dsRNA cause the level of
P-eIF2α to gradually increase until it reaches a plateau level from
∼5 h p.i. onwards. At these high P-eIF2α levels, ISRIB no longer
antagonized the ISR. Upon further increasing the ISRIB con-
centration (up to 1,600 nM), ISRIB still failed to suppress the ISR
(SI Appendix, Fig. S4). By contrast, up to ∼4 h p.i. when P-eIF2α
levels were ∼35% of the maximal level, ISRIB potently suppressed
the ISR in infected cells.
ISRIB Fails to Antagonize the Effects of High P-eIF2α Levels Induced
by Poly(I:C). Virus infections cause extensive changes in multiple
processes in the host cell. Hence, we could not exclude that some
virus-induced change(s) in one way or the other affected the
ISRIB’s ability to suppress the ISR in infected cells. To provide
more direct support for the link between the level of P-eIF2α and
the ability of ISRIB to counteract the dsRNA-induced ISR, we
next tested the efficacy of ISRIB in cells transfected with in-
creasing concentrations of poly(I:C), a dsRNA mimic that—like
EMCV-LZn infection—triggers the PKR branch of the ISR (Fig.
3). In the absence of ISRIB, we observed SG formation in cells
transfected with 0.25 ng of poly(I:C) or more. ISRIB prevented
SG formation only in cells transfected with relatively low poly(I:C)
concentrations (1 ng or less) but not when larger amounts of
poly(I:C) were used (Fig. 3A). At the highest concentration of
poly(I:C) at which ISRIB could counteract the ISR (i.e., 1 ng),
the P-eIF2α level was ∼45% of the maximum (Fig. 3B). Trans-
fection of 2 ng of poly(I:C) induced >70% of the maximum
P-eIF2α concentration and rendered ISRIB ineffective. Together,
these data suggest that a threshold level of P-eIF2α exists in the
range of 45–70% of the maximum, above which ISRIB can no
longer antagonize the ISR.
ISRIB also Fails to Antagonize High P-eIF2α Levels Induced by Arsenite
Treatment. Thus far, we tested ISRIB in cells exposed to EMCV-
LZn infection or poly(I:C) transfection, both of which induce the
ISR via activation of the dsRNA sensor PKR. Since ISRIB acts
downstream of P-eIF2α, we expected similar results irrespective of
which stress sensor was activated. To provide further support for
this notion, we used multiple arsenite concentrations to induce
HRI-mediated ISR activation. Again, we correlated the ability of
ISRIB to counteract SG formation (Fig. 4A) to P-eIF2α levels (Fig.
4B). In the absence of ISRIB, SG formation was observed in cells
treated with 50 μM arsenite or more. The presence of ISRIB in-
creased the arsenite concentration required to induce SG for-
mation to 200 μM or more (Fig. 4A). The highest arsenite
concentration at which ISRIB blocked SG formation (100 μM)
resulted in ∼40% of the maximum P-eIF2α level. At 200 μM
arsenite, which induced ∼75% P-eIF2α, ISRIB showed no ef-
fect. Importantly, the P-eIF2α threshold level above which
ISRIB no longer antagonized the ISR (between 40% and 70%)
was similar to that observed in poly(I:C)-transfected cells (i.e.,
between 45% and 70%).
To directly determine ISRIB’s influence on translation rates,
we performed [35S]methionine pulse labeling to monitor active
translation in cells exposed to different arsenite concentrations
in the presence or absence of ISRIB (Fig. 4C). In the absence of
ISRIB, arsenite concentrations of 25 μM and higher were suffi-
cient to inhibit translation. ISRIB largely rescued translation in
cells treated with low arsenite concentrations (between 25 μM
and 100 μM). However, upon treatment with higher arsenite
concentrations (>250 μM), translation was severely impaired,
even in the presence of ISRIB. These data are in line with our
immunofluorescence data (Fig. 4A) showing the formation of
-I
SR
IB
+  
IS
R
IB
A EMCV-LZn
4 h 4.5 h 5 h
50 μm
SG
+
ce
lls
 (%
)
40
60
80
100
0
0
20
5.5 h 6 h
B
3 h
EMCV-LZn
4 h 5 h 6 h
P-eIF2α
2 4 6
Time (h p.i.)
Time (h p.i.)
0 2 4 6
0
100
P-
eI
F2
α 
( %
) 80
60
40
20
- ISRIB
+ ISRIB
***
Fig. 2. ISRIB inhibits only the virus-induced ISR early in infection, when P-eIF2α
levels are relatively low. HeLa-R19 cells were infected at MOI 20 with EMCV-LZn.
(A) At the indicated time points, cells were fixed in PFA and analyzed by an
immunofluorescence assay using antibodies specific to SG marker G3BP1. Per-
centages of SG positive cells were quantified from at least four images. Rep-
resentative images are shown on the Left, quantification is shown on the Right.
Error bars indicate SEM. Statistical significance was analyzed by a two-way
ANOVA, with Bonferroni post hoc test (***P < 0.001). (B) At the indicated
time points, cells were harvested and the level of P-eIF2α was analyzed by flow
cytometry. Results are shown as histograms (Left) and the percentage increase
in mean fluorescence intensity is shown on the Right. Mock-infected cells are
set at 0% induction; maximum P-eIF2α level was set at 100% induction. Shown
is a representative of two independent experiments.
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Fig. 3. ISRIB fails to counteract high poly(I:C)-induced P-eIF2α levels. HeLa-R19
cells were transfected with a total of 100 ng RNA, out of which the indicated
amounts of poly(I:C), supplemented with total cellular RNA. (A) Six hours
posttransfection, cells were fixed in PFA and SG formation was analyzed by an
immunofluorescence assay. Shown are representative images (Left) and quan-
tifications of at least four images per sample (Right). Error bars indicate SEM.
Statistical significance was analyzed by a two-way ANOVA, with Bonferroni
post hoc test (**P < 0.01; ***P < 0.001). (B) Six hours posttransfection, P-eIF2α
levels in the transfected cell populations were analyzed by flow cytometry.
Results are shown as histograms (Left) and the percentage increase in P-eIF2α
mean fluorescence intensity is shown on the Right. Mock-infected cells are set
at 0% induction; maximum P-eIF2α level was set at 100% induction. Shown is a
representative of two independent experiments.
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SGs in ISRIB-treated cells exposed to arsenite concentrations of
200 μM and higher.
Besides the inhibitory effect on general translation, the ISR
mediates enhanced translation of a subset of mRNAs that contain
uORFs, such as ATF4 mRNA. To test the effects of ISRIB on the
expression of these stress-induced proteins, we used a HEK293T
reporter cell line that expresses firefly luciferase under the control
of the ATF4 uORFs (19). To activate the ISR, we treated cells with
the indicated arsenite concentrations for 2 h. In the absence of
ISRIB, we observed increased ATF4 reporter expression upon
treatment with arsenite concentrations of 32 nM and higher (Fig.
5A). This is in line with a previous report which shows that less P-
eIF2α is required for the induction of ATF4 than for translational
inhibition (37). At low arsenite concentrations (32 nM–4 μM),
ISRIB prevented the enhanced expression of the ATF4 reporter
(Fig. 5B). In contrast, we found that upon treatment with higher
concentrations of arsenite (≥20 μM), ATF4 reporter expression was
induced even in the presence of ISRIB.
Discussion
In this study, we provide evidence that ISRIB antagonizes the ISR
only when P-eIF2α levels are below a critical threshold. By ana-
lyzing translation efficiency and stress granule formation in HeLa or
U2OS cells infected with a recombinant picornavirus lacking its
PKR antagonist, we showed that ISRIB inhibited the ISR early in
infection, when levels of viral dsRNA and P-eIF2α were relatively
low, but not at later time points when levels of dsRNA and P-eIF2α
were high. To extend this observation, we performed a detailed
analysis of the P-eIF2α levels and the ability of ISRIB to inhibit the
ISR upon treatment of HeLa cells with varying concentrations of
poly(I:C) or arsenite. We found that the level of P-eIF2α correlated
with the concentration of stress trigger used but reached a plateau
under severe stress conditions. Thus, the extent of eIF2α phos-
phorylation is graduated, quantitatively reflecting the severity of the
stress situation. Importantly, the P-eIF2α concentration continued
to increase even beyond the concentration necessary to suppress
protein synthesis. Irrespective of the stress inducer used, ISRIB
antagonized the ISR only when P-eIF2α levels were below a critical
threshold. This threshold was determined to be somewhere be-
tween 45% and 70% of the maximum P-eIF2α level that could be
observed in HeLa cells and was similar in cells infected with virus,
transfected with poly(I:C), or treated with arsenite. Using an ATF4
reporter cell line, we also showed that ISRIB failed to block the
expression of stress-induced proteins in the presence of high in-
tracellular P-eIF2α levels. Taken together, our data show that
ISRIB is effective only under conditions of limited stress.
Early studies of translation repression by P-eIF2α have shown
that partial eIF2α phosphorylation could efficiently block trans-
lation. In reticulocyte lysates, translation initiation was suppressed
when the fraction of phosphorylated eIF2α was increased from
∼10% under basal conditions to 20–40% (38). In line with these
data, our results show that only ∼20% of the maximum level of P-
eIF2α is sufficient to block translation and induce the formation of
SGs in living cells. In the presence of ISRIB, this threshold level of
P-eIF2α was increased to 45–70% of the maximum. Importantly,
this threshold level of P-eIF2α appeared independent of the stress
trigger, and hence of the eIF2α kinase involved. These data are in
line with published in vitro data showing that ISRIB increased the
GEF activity of eIF2B in the presence of P-eIF2, but failed to do so
when the P-eIF2:eIF2 ratio was increased further (24). Taken to-
gether, the data from these in vitro GEF assays and our data from
assays in live cells suggest that ISRIB desensitizes cells to P-eIF2α,
unless the P-eIF2α concentration exceeds a critical threshold level.
Formation of decameric eIF2B requires dimerization of eIF2B
(βγδe) subcomplexes. The resulting octamers contain an interface
for association of an eIF2Bα dimer (25). Since eIF2Bα is essential
for P-eIF2’s ability to inhibit eIF2B (39), P-eIF2 likely binds only the
full eIF2B decamer, not its subcomplexes. Thereby, P-eIF2 likely
promotes eIF2B decamer formation and mediates sequestration
of eIF2B subcomplexes into inactive P-eIF2•eIF2B complexes.
Consequently, high P-eIF2 concentrations may deplete the
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Fig. 4. ISRIB does not rescue translation in the presence of high P-eIF2α
levels irrespective of the eIF2α kinase involved. HeLa-R19 cells were treat-
ed with the indicated arsenite concentrations for 1 h. (A) Cells were fixed in
PFA and SG formation was analyzed by an immunofluorescence assay, using
antibodies specific to G3BP1. Shown are representative images (Left) and
quantifications of at least four images per sample (Right). Error bars indicate
SEM. Statistical significance was analyzed by a two-way ANOVA, with Bon-
ferroni post hoc test (***P < 0.001). (B) P-eIF2α levels were analyzed by flow
cytometry. Results are shown as histograms (Left) and the percentage in-
crease in P-eIF2α mean fluorescence intensity is shown on the Right. Mock-
infected cells are set at 0% induction; maximum P-eIF2α level was set at
100% induction. Shown is a representative of three independent experi-
ments. (C) Cells were treated for 30 min with the indicated arsenite con-
centrations, and subsequently translation was pulse labeled using 35S Met/
Cys for another 90 min in medium containing the same arsenite concen-
trations. 35S incorporation into newly synthesized proteins was analyzed
using a phosphor imager (Left) and quantified using ImageJ software
(Right). Error bars indicate SEM of duplicate measurements. A representative
of two independent experiments is shown. Statistical significance was ana-
lyzed by a two-way ANOVA, with Bonferroni post hoc test (**P < 0.01).
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Fig. 5. ISRIB interferes with ATF4 expression only within a defined window of P-
eIF2α concentrations. HEK293T cells stably expressing the ATF4-luc reporter were
treated with the indicated amounts of arsenite for 2 h in the presence or absence
of ISRIB. Shown are the relative luminescence units (RLU) values (A), plotted once
more as the difference in RLU values between cells treatedwith ISRIB andwithout
ISRIB (B). Error bars indicate SEM of triplicate measurements. A representative of
two independent experiments is shown. Statistical significance was analyzed by a
two-way ANOVA, with Bonferroni post hoc test (*P < 0.05; **P < 0.01).
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cytoplasmic pools of eIF2B building blocks. This provides a
plausible explanation for ISRIB’s lack of effect in the presence of
high P-eIF2 levels, since the absence of eIF2B subcomplexes
prevents ISRIB from assembling active eIF2B decamers.
In most studies that investigate the ISR, eIF2α phosphorylation
is induced by exposing cells to sodium arsenite, thapsigargin, tuni-
camycin, DTT, MG132, poly(I:C), or heat shock. It is unclear to
what extent these treatments reflect physiologically relevant stress
situations. In this study, we used a virus lacking its PKR antagonist
to assess the ability of ISRIB to antagonize the ISR induced by a
viral stress trigger (i.e., viral dsRNA) with natural intracellular lo-
calization and in physiological quantities. We showed that ISRIB
inhibits the ISR early in infection, when little viral dsRNA has been
produced and P-eIF2α levels are relatively low, but not late in in-
fection, when viral dsRNA and P-eIF2α levels are high. Thus, levels
of P-eIF2α that can no longer be antagonized by ISRIB can be
reached in living cells under natural conditions.
While the ISR protects cells from stressful situations, dysregu-
lated ISR signaling may have pathological consequences in vivo, and
may be involved in the presentation of cognitive defects in neuro-
logical disorders like Parkinson’s disease, Alzheimer’s disease, Hun-
tington’s disease, amylotropic lateral sclerosis (ALS), and prion
diseases (40–44). ISRIB provided significant beneficial effects in
a mouse model of prion disease, and it also reversed neurological
damage caused by traumatic brain injury (21), all without exhibiting
overt toxic side effects (27, 45). By contrast, pharmacological in-
hibition of PERK caused pancreatic toxicity in mice, and knock-
down of PKR had an aberrant effect on cytokinesis (15, 28).
Paradoxically, ISRIB did not display such adverse side effects in vivo
(27). Our observation that ISRIB is functional only within a narrow
range of P-eIF2α levels resolves this paradox. According to this no-
tion, ISRIB does not negatively affect high(er) P-eIF2α levels that
may be relevant for certain stages during cell growth or proliferation.
The fact that ISRIB has beneficial effects in vivo against several
neurological disorders and other stress-induced pathologies suggests
that P-eIF2α levels would be relatively modest under these condi-
tions. These considerations stress the importance to obtain quanti-
tative data on how much eIF2α phosphorylation occurs in
neurological disorders. More insight into levels of eIF2B, eIF2,
and P-eIF2α and the assembly state of these multiprotein
complexes in different cell/tissue types exposed to different
stress and disease conditions will be invaluable to predict and/
or evaluate effects of ISRIB treatment.
Materials and Methods
Chemical Inhibitors and RNA Ligands. ISRIB (SML0843) and puromycin (P9620)
were purchased at Sigma-Aldrich and used at 200 nM and 20 μg/mL, re-
spectively, unless indicated otherwise. Poly(I:C) was purchased at GE
Healthcare. Sodium arsenite was purchased at Riedel-de-Haën.
Cells and Viruses. HEK293T, HeLa-R19, U2OS, and BHK-21 cells were maintained
in DMEM (Lonza) supplemented with 10% FCS and penicillin–streptomycin
(100 units/mL and 100 μg/mL). Recombinant EMCV with Zn-finger domain mu-
tation in the Leader protein (EMCV-LZn, ref. 31) was propagated in BHK-21 cells.
Poly(I:C) Transfection. Semiconfluent monolayers of HeLa-R19 cells grown in
24-well clusters were transfected with poly(I:C) using Lipofectamine 2000
(Thermo Fisher Scientific) according to manufacturer’s instructions. For each
transfection, the indicated amounts of poly(I:C) were combined with total
cellular RNA from resting HeLa-R19 to a constant 100 ng per well.
ATF4 Reporter Assay. HEK293T cells carrying an ATF4 luciferase reporter (19)
were plated on polylysine-coated 96-well plates (Greiner Bio-One) at 25,000
cells per well. Cells were simultaneously treated with or without 200 nM
ISRIB, and with sodium arsenite at increasing concentrations. Luminescence
was measured using One Glo (Promega) as specified by the manufacturer.
Ribopuromycilation Assay. Cells in 10-cm dishes were either mock treated,
treated with 50 μM arsenite, or infected with EMCV-LZn [multiplicity of infection
(MOI) = 20] in the presence or absence of 200 nM ISRIB. After the indicated
incubation time, puromycin (20 μg/mL) was added to themedium and incubated
for another 15 min. Cells were collected and used for Western blot analysis.
The 35S Pulse Labeling of Active Translation. Semiconfluent cell monolayers
were first starved in medium lacking methionine and cysteine for 30 min and
then treated with the indicated arsenite concentrations for 30 min with or
without ISRIB. Subsequently, newly synthesized proteins were labeled with
50 μCi/mL 35S Met/Cys (Perkin-Elmer) for another 90 min. Cells were then
lysed, and proteins were separated using SDS/PAGE. Subsequently, gels were
dried on Whatman paper and analyzed using a phosphor imager.
Immunofluorescence Assay. Immunofluorescence assays were performed as
described previously (46), using primary antibody mouse-α-G3BP1 (611126,
1:1,000; BD Biosciences), and secondary antibody donkey-α-mouse-Alexa488
(A-21202, 1:200; Thermo Fisher Scientific).
Western Blot Analysis. Western blot assays were performed as described
previously (46), using primary antibodies rabbit-α-puromycin (MABE343,
1:1,000; Merck Millipore), rabbit-α-eIF2α (9722, 1:2,000; Cell Signaling), rab-
bit-α-eIF2α-P (ab32157, 1:1,000; Abcam), or mouse-α-tubulin (T9026, 1:5,000;
Sigma-Aldrich), and secondary antibodies goat-α-mouse-IRDye680 (1:15,000;
LI-COR) or goat-α-rabbit-IRDye800 (1:15,000; LI-COR).
Flow Cytometry Analysis of eIF2α Phosphorylation. Cells were released using
trypsin and fixed with paraformaldehyde (2% in PBS) for 20 min. Cells were
washed once with FACS buffer (PBS + 1% BSA) and incubated in ice-cold
methanol for 10 min. Cells were washed once with FACS buffer and in-
cubated for 45 min with primary rabbit-α-eIF2α-P (ab32157, 1:100; Abcam)
and then for 45 min with donkey-α-rabbit-Alexa647 (A-31573, 1:200; Thermo
Fisher Scientific) diluted in FACS buffer at room temperature. In between
and after the incubations, the cells were washed, twice each time, with FACS
buffer. Finally, the cells were suspended in PBS + 1% paraformaldehyde and
analyzed on the FACSCanto II (BD Biosciences).
Purification of eIF2α and Phosphorylated eIF2α. Human eIF2, codon optimized
for Escherichia coli, was cloned into a pET28a expression vector. This plasmid
was cotransformed with the chaperone plasmid pG-Tf2 (Takara Bio) and, for
phosphorylated eIF2, an additional plasmid expressing PERK kinase domain.
eIF2α was purified by sequential nickel-affinity, cation-exchange, and size-
exclusion chromatography. Details are included in SI Appendix.
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